Rohto Pharmaceutical Co.,Ltd. (RPHCF)
USD 20.09
(-24.56%)
USD 20.09
(-24.56%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 40.04 Billion JPY | 15764.33% |
| 2023 | 252.44 Million JPY | 10.31% |
| 2022 | 228.85 Million JPY | 15.65% |
| 2021 | 197.89 Million JPY | -6.64% |
| 2020 | 211.95 Million JPY | 14.16% |
| 2019 | 185.67 Million JPY | 5.28% |
| 2018 | 176.35 Million JPY | 27.17% |
| 2017 | 138.67 Million JPY | -0.62% |
| 2016 | 139.53 Million JPY | -98.94% |
| 2015 | 13.15 Billion JPY | -21.77% |
| 2014 | 16.82 Billion JPY | 16.97% |
| 2013 | 14.38 Billion JPY | 5.55% |
| 2012 | 13.62 Billion JPY | 3.96% |
| 2011 | 13.1 Billion JPY | 4.47% |
| 2010 | 12.54 Billion JPY | 7.78% |
| 2009 | 11.63 Billion JPY | -10.73% |
| 2008 | 13.03 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | 40.04 Billion JPY | 15764.33% |
| 2024 Q4 | 4.78 Billion JPY | 4623.52% |
| 2024 Q3 | 101.32 Million JPY | 60.59% |
| 2024 Q2 | 63.09 Million JPY | -21.08% |
| 2024 Q1 | 79.94 Million JPY | 98.07% |
| 2023 Q3 | 93.99 Million JPY | 75.21% |
| 2023 Q4 | 40.35 Million JPY | -57.06% |
| 2023 Q1 | 61.08 Million JPY | 31.19% |
| 2023 Q2 | 53.64 Million JPY | -12.18% |
| 2023 FY | 252.44 Million JPY | 10.31% |
| 2022 Q3 | 84.06 Million JPY | 31.12% |
| 2022 Q4 | 46.56 Million JPY | -44.61% |
| 2022 FY | 228.85 Million JPY | 15.65% |
| 2022 Q1 | 54.14 Million JPY | 17.6% |
| 2022 Q2 | 64.1 Million JPY | 18.41% |
| 2021 Q3 | 6.28 Billion JPY | -8.96% |
| 2021 Q2 | 6.9 Billion JPY | 93.03% |
| 2021 FY | 197.89 Million JPY | -6.64% |
| 2021 Q1 | 3.57 Billion JPY | -27.91% |
| 2021 Q4 | 46.03 Million JPY | -99.27% |
| 2020 FY | 211.95 Million JPY | 14.16% |
| 2020 Q3 | 7.73 Billion JPY | 18.37% |
| 2020 Q4 | 4.95 Billion JPY | -35.87% |
| 2020 Q1 | 3.86 Billion JPY | 6.63% |
| 2020 Q2 | 6.53 Billion JPY | 69.25% |
| 2019 Q4 | 3.62 Billion JPY | -44.15% |
| 2019 FY | 185.67 Million JPY | 5.28% |
| 2019 Q3 | 6.48 Billion JPY | 14.75% |
| 2019 Q2 | 5.64 Billion JPY | 11.62% |
| 2019 Q1 | 5.06 Billion JPY | 45.43% |
| 2018 Q2 | 5.22 Billion JPY | 52.11% |
| 2018 Q1 | 3.43 Billion JPY | 12.23% |
| 2018 FY | 176.35 Million JPY | 27.17% |
| 2018 Q4 | 3.48 Billion JPY | -49.94% |
| 2018 Q3 | 6.95 Billion JPY | 33.13% |
| 2017 Q2 | 4.24 Billion JPY | 91.61% |
| 2017 FY | 138.67 Million JPY | -0.62% |
| 2017 Q1 | 2.21 Billion JPY | -42.02% |
| 2017 Q4 | 3.05 Billion JPY | -48.39% |
| 2017 Q3 | 5.92 Billion JPY | 39.52% |
| 2016 FY | 139.53 Million JPY | -98.94% |
| 2016 Q2 | 5.31 Billion JPY | 186.27% |
| 2016 Q4 | 3.82 Billion JPY | -18.4% |
| 2016 Q1 | 1.85 Billion JPY | -55.34% |
| 2016 Q3 | 4.68 Billion JPY | -11.85% |
| 2015 Q4 | 4.15 Billion JPY | 9.28% |
| 2015 Q2 | 4.49 Billion JPY | 545.48% |
| 2015 Q1 | 697 Million JPY | -81.1% |
| 2015 Q3 | 3.8 Billion JPY | -15.43% |
| 2015 FY | 13.15 Billion JPY | -21.77% |
| 2014 Q4 | 3.68 Billion JPY | -35.54% |
| 2014 FY | 16.82 Billion JPY | 16.97% |
| 2014 Q3 | 5.72 Billion JPY | 25.27% |
| 2014 Q2 | 4.56 Billion JPY | 60.32% |
| 2014 Q1 | 2.84 Billion JPY | -27.03% |
| 2013 Q1 | 2.66 Billion JPY | 9.51% |
| 2013 Q2 | 2.96 Billion JPY | 11.58% |
| 2013 Q3 | 4.84 Billion JPY | 63.38% |
| 2013 FY | 14.38 Billion JPY | 5.55% |
| 2013 Q4 | 3.9 Billion JPY | -19.51% |
| 2012 FY | 13.62 Billion JPY | 3.96% |
| 2012 Q1 | 2.68 Billion JPY | -11.03% |
| 2012 Q2 | 3.61 Billion JPY | 34.61% |
| 2012 Q3 | 4.89 Billion JPY | 35.22% |
| 2012 Q4 | 2.42 Billion JPY | -50.34% |
| 2011 Q1 | 2.02 Billion JPY | -40.14% |
| 2011 Q4 | 3.02 Billion JPY | -35.79% |
| 2011 Q3 | 4.7 Billion JPY | 41.57% |
| 2011 Q2 | 3.32 Billion JPY | 63.81% |
| 2011 FY | 13.1 Billion JPY | 4.47% |
| 2010 Q1 | 2.87 Billion JPY | 10.29% |
| 2010 FY | 12.54 Billion JPY | 7.78% |
| 2010 Q4 | 3.38 Billion JPY | -12.59% |
| 2010 Q3 | 3.87 Billion JPY | 62.38% |
| 2010 Q2 | 2.38 Billion JPY | -16.89% |
| 2009 Q2 | 2.87 Billion JPY | 0.0% |
| 2009 FY | 11.63 Billion JPY | -10.73% |
| 2009 Q4 | 2.6 Billion JPY | -42.61% |
| 2009 Q3 | 4.53 Billion JPY | 58.08% |
| 2008 FY | 13.03 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | -77.48 Thousand USD | 51682274.244% |
| Bruush Oral Care Inc. | -9.15 Million USD | 437694.107% |
| CCA Industries, Inc. | -192.39 Thousand USD | 20815826.144% |
| DSwiss, Inc. | -51.52 Thousand USD | 77733019.255% |
| EOS, Inc. | -772.6 Thousand USD | 5183575.73% |
| Greyson International, Inc. | -75.9 Thousand USD | 52760787.702% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | 120 Thousand USD | -33373233.333% |
| Infusion Brands International, Inc. | -6.67 Million USD | 600028.514% |
| Mandom Corporation | 13.35 Million USD | -299823.304% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | -543.89 Thousand USD | 7363299.447% |
| Oliveda International, Inc. | -1.3 Million USD | 3058226.394% |
| PacificHealth Laboratories, Inc. | -474.21 Thousand USD | 8445161.132% |
| Prosperous Future Holdings Limited | -26.15 Million USD | 153241.371% |
| PURE Bioscience, Inc. | -3.13 Million USD | 1279180.166% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | -490.37 Thousand USD | 8166911.114% |
| Sentient Brands Holdings Inc. | -250.85 Thousand USD | 15964446.505% |
| Sunset Capital Assets, Inc. | -249.51 Thousand USD | 16050309.004% |
| The Stephan Co. | -65 Thousand USD | 61612407.692% |
| Turner Valley Oil & Gas, Inc. | -145.83 Thousand USD | 27460706.975% |
| Winning Brands Corporation | -267.94 Thousand USD | 14946227.808% |
| Warpaint London PLC | 23.55 Million USD | -169884.595% |
| Zoono Group Limited | -2.29 Million USD | 1743771.336% |
| Zurvita Holdings, Inc. | -2.79 Million USD | 1434208.638% |